Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This clinical trial will prove whether a large number of people with intellectual disability
and treatment-resistant psychosis could benefit from the use of clozapine. Benefit will mean
a measurable significant improvement in subjects' clinical response and quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla